HO-1 metabolite BV inhibits PRRSV replication in vitro. BV suppression of PRRSV infection is independent on ROS reduction. BV secondary metabolite BR mediates the antiviral effect of BV. BR inhibits PRRSV infection via a NO-dependent cGMP/PKG signaling pathway.